User profiles for A. Rostom

Ahmed Rostom

World Bank, George Washington University and Economic Research Forum
Verified email at gwu.edu
Cited by 590

Decision aids for patients facing health treatment or screening decisions: systematic review

AM O'Connor, A Rostom, V Fiset, J Tetroe, V Entwistle… - Bmj, 1999 - bmj.com
Objective: To conduct a systematic review of randomised trials of patient decision aids in
improving decision making and outcomes. Design: We included randomised trials of …

American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease

A Rostom, JA Murray, MF Kagnoff - Gastroenterology, 2006 - Elsevier
This technical review addresses the state of evidence for celiac disease epidemiology,
detection by serologic testing, diagnosis by biopsy, treatment, and outcome. It updates the …

Prevention of NSAID‐induced gastroduodenal ulcers

Cochrane Gut Group, A Rostom… - Cochrane database …, 1996 - cochranelibrary.com
Background Non‐steroidal anti‐inflammatory drugs (NSAIDs) are important agents in the
management of arthritic and inflammatory conditions, and are among the most frequently …

[HTML][HTML] Celiac disease: summary

A Rostom, C Dubé, A Cranney, N Saloojee… - AHRQ evidence …, 2004 - ncbi.nlm.nih.gov
Celiac disease (CD) is a disorder of small bowel malabsorption. It is characterized by mucosal
inflammation, villous atrophy, and crypt hyperplasia, which occur upon exposure to gluten…

Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review

A Rostom, K Muir, C Dubé, E Jolicoeur… - Clinical …, 2007 - Elsevier
Background & Aims: Nonselective non-steroidal anti-inflammatory drugs (NSAIDs) and
cyclooxygenase-2 inhibitors (COX-2s) are used to treat a variety of arthritic and inflammatory …

Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials

…, P Klvana, Y Niv, S Ardizzone, O Alexeeva, A Rostom… - Jama, 2008 - jamanetwork.com
Context Maintenance therapy for Crohn disease features the use of immunosuppressive
drugs, which are associated with an increased risk of infection. Identification of safe and …

[HTML][HTML] Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

…, J Gisbert, VK Sharma, A Rostom… - Health Technology …, 2007 - europepmc.org
Objectives To evaluate the clinical effectiveness and cost-effectiveness of proton pump
inhibitors (PPIs) in the prevention and treatment of acute upper gastrointestinal (UGI) …

[BOOK][B] The role of Islamic finance in enhancing financial inclusion in Organization of Islamic Cooperation (OIC) countries

M Mohieldin, A Rostom, M Mohieldin, X Fu, Z Iqbal - 2011 - platform.almanhal.com
The paper identifies gaps currently existing in Organization of Islamic Cooperation (OIC)
countries on each front, that is, Sharīʿah-compliant micro-finance and financing for small and …

Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks

A Rostom, P Moayyedi, R Hunt… - Alimentary …, 2009 - Wiley Online Library
Background Nonsteroidal anti‐inflammatory drugs (NSAIDs) are widely used, but are not
without risks. Aim To provide evidence‐based management recommendations to help …

The probiotic VSL# 3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease

…, R Enns, A Bitton, N Chiba, P Paré, A Rostom… - Clinical …, 2015 - Elsevier
Background & Aims Probiotic formulations of single species of bacteria have not been effective
in preventing the recurrence of Crohn’s disease after surgery. We investigated the ability …